A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Obesity
Interventions
DRUG

Retatrutide

Administered SC

DRUG

Tirzepatide

Administered SC

Trial Locations (65)

10075

New York Gastroenterology Associates, New York

10595

Westchester Medical Center, Valhalla

12203

Albany Medical College, Division of Community Endocrinology, Albany

21109

Diabetes Zentrum Wilhelmsburg, Hamburg

22607

Diabeteszentrum Hamburg West, Hamburg

22911

Charlottesville Medical Research, Charlottesville

23758

RED-Institut GmbH, Oldenburg in Holstein

27408

PharmQuest Life Sciences, LLC, Greensboro

28112

Monroe Biomedical Research, Monroe

28401

Accellacare - Wilmington, Wilmington

29607

Tribe Clinical Research, LLC, Greenville

30038

Pivotal Research Solutions, Stonecrest

30501

Northeast Georgia Medical Center, Gainesville

31904

ClinCept Clinical Research - MH, Columbus

32960

Einstein Clinical Research, Vero Beach

33024

Encore Medical Research, Hollywood

33135

Suncoast Research Group, Miami

33186

Onhealth Research Center, Miami

33351

Precision Clinical Research, Sunrise

37421

WR-Clinsearch, LLC, Chattanooga

45136

InnoDiab Forschung Gmbh, Essen

45355

Medizentrum Essen Borbeck, Essen

45429

PriMED Clinical Research, Dayton

48075

Great Lakes Research Institute, Southfield

48706

Great Lakes Research Group, Inc., Bay City

49808

Diabetologische Schwerpunktpraxis Dr. Staudenmeyer & Dr. Schiwietz, Lingen

50265

Integrated Clinical Trial Services, Inc., West Des Moines

51069

Zentrum fur klinische Forschung - Köln, Cologne

58104

Lillestol Research, Fargo

60611

Northwestern University, Chicago

63303

StudyMetrix Research, City of Saint Peters

70808

Pennington Biomedical Research Center, Baton Rouge

77057

Next Level Urgent Care, Houston

77079

Houston Research Institute, Houston

78048

Gemeinschaftspraxis Prof. Dr. med. Stephan Jacob, Dr. med. Frohmut Jacob, Villingen-Schwenningen

78231

Consano Clinical Research, LLC, Shavano Park

78526

Headlands Horizons LLC, Brownsville

80012

Lynn Institute of Denver, Aurora

84790

Chrysalis Clinical Research, St. George

85283

Medical Advancement Centers of Arizona, Tempe

89074

Las Vegas Endocrinology, Henderson

91978

Encompass Clinical Research, Spring Valley

92103

Artemis Institute for Clinical Research, San Diego

92663

Mary & Dick Allen Diabetes Center, Newport Beach

94598

Diablo Clinical Research, Inc., Walnut Creek

96814

East-West Medical Research Institute, Honolulu

06610

Bridgeport Hospital, Bridgeport

06519

Yale University School of Medicine, New Haven

B1704ETD

DIM Clínica Privada, Ramos Mejía

C1120AAC

Centro Médico Viamonte, Buenos Aires

C1405BUB

Consultorio de Investigación Clínica EMO SRL, Buenos Aires

C1425AGC

Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada, Buenos Aires

C1056ABI

Centro de Investigaciones Metabólicas (CINME), Buenos Aires

04107

AmBeNet GmbH, Leipzig

60-589

Centrum Zdrowia Metabolicznego Pawel Bogdanski, Poznan

61-853

Nzoz Neuro-Kard Ilkowski i Partnerzy SPL, Poznan

20-333

Gabinety TERPA, Lublin

20-718

Ekamed, Lublin

15-276

Uniwersytecki Szpital Kliniczny w Białymstoku, Bialystok

15-281

Gabinet Leczenia Otylosci i Chorob Dietozaleznych - dr hab. n. med. Lucyna Ostrowska, Bialystok

15-351

Zdrowie Osteo-Medic, Bialystok

15-435

NZOZ Specjalistyczny Ośrodek Internistyczno-Diabetologiczny, Bialystok

41-709

NZOZ Przychodnia Specjalistyczna Andrzej Wittek, Henryk Rudzki, Ruda Śląska

90-338

Centrum Terapii Wspolczesnej J. M. Jasnorzewska Spolka Komandytowo-Akcyjna, Lodz

00716

Ponce Medical School Foundation Inc., Ponce

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT06662383 - A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity | Biotech Hunter | Biotech Hunter